Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1073/week)
Manufacturing
(515/week)
Technology
(1039/week)
Energy
(410/week)
Other Manufacturing
(313/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Skeletal disorders
Jun 05, 2018
Ampio Provides Scientific Update and Links to Peer Review Publications
May 29, 2018
Ampio Updates Regulatory and IP Activities
May 22, 2018
Ampio Updates Scientific presentations and publications on Ampion(TM)
May 21, 2018
FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis
May 14, 2018
Ampio Provides Corporate Update
May 08, 2018
Launch of New National Osteoarthritis Awareness Campaign: "StandUP2OA" Has Unique Focus on Disease Prevention
May 03, 2018
Keck School of Medicine of USC receives $4 million for arthritis research
May 01, 2018
New research ranks the effectiveness of nonsurgical treatments for knee osteoarthritis
Apr 27, 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Apr 26, 2018
Medivir AB: Data From the MIV-711 Initial Phase IIa Study Will be Presented at the OARSI World Congress on April 27
Apr 18, 2018
Musculoskeletal Disorders Pipeline Database 2018: Osteoporosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Ankylosing Spondylitis
Apr 17, 2018
OrthoTrophix Will Present Data on Long-Term Clinical Benefit of TPX-100 in Mild to Severe Knee Osteoarthritis Patients at OARSI Annual Meeting 2018
Apr 17, 2018
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
Apr 12, 2018
Ampio Updates Regulatory, Clinical and NYSE Activities
Apr 03, 2018
European Commission Approves Expanded Indication For Amgen's XGEVA® (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
Mar 28, 2018
MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee
Mar 26, 2018
Evidence for Delay of Total Knee Replacement (TKR) for Patients with Severe Osteoarthritis of the Knee Receiving Three Intra-articular (IA) Ampion(TM) Injections
Mar 21, 2018
Global Osteoarthritis Treatment Market to Reach US$ 11,618.6 Mn by 2025 - Persistence Market Research
Mar 20, 2018
Weight Loss After Stomach-Narrowing Surgery Eases Chronic Knee Pain
Mar 09, 2018
AmnioFix® Injectable Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for the Treatment of Osteoarthritis of the Knee
‹‹
Page 5
››
Latest News
Aug 26, 2025
Save Big—and Shop Smart—During Lenovo’s Labour Day Sale
Aug 26, 2025
James Hardie Announces Participation at Upcoming Investor Conferences
Aug 26, 2025
Wilson & Company Celebrates National Nonprofit Day with Launch of Higher Giving Philanthropy Program
Aug 26, 2025
Nickolas Asset Management & The Reinhart Family of Companies Announce Kreate’s Acquisition of Precision...
Aug 26, 2025
Korean Air purchases over 100 Boeing aircraft
Aug 26, 2025
26 Connecticut Municipal Leaders Unite to Oppose Proposed Sale of Aquarion Water Company
Aug 26, 2025
Avery Dennison to Acquire Meridian’s Flooring Business
Aug 26, 2025
CACI Protects Canadian Armed Forces Through New C-UAS Technology Contract
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events